Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
coopERA: Giredestrant vs Anastrozole in Early Breast Cancer
NCT04436744Phase 2Completed
- Sponsor
- Roche
- Start
- Sep 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of giredestrant in breast cancer, sponsored by Roche. Started Sep 2020; status: completed.
02
Drugs
giredestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04436744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04436744.